New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

While around 30 percent of the city's 100,000 residents identify as Hispanic, an estimated 40 percent hail from the Middle ...

Talking shop while breaking bread should be fun. We’ve travelled the country to find the best restaurants for business.

Though all bourbon is whiskey, not all whiskey is bourbon. So, what sets them apart? Here are the key things to know about ...

The new acquisition from Boston Pharmaceuticals adds to a wave of dealmaking undertaken by GSK to build its liver disease ...

Akero Therapeutics, Inc.’s AKRO share price has dipped by 6.47%, which has investors questioning if this is right time to buy ...

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

GSK to pay $1.2B upfront to Boston Pharmaceuticals for efimosfermin alfa, a MASH drug candidate. Deal includes $800M in ...

Below is a brief background and tasting notes on the “Best of Class” and “Best of Category.” American Rye Whiskeys from the ...

Mashle: Magic and Muscles features an overpowered protagonist, Mash Burnedead, who lacks magic but makes up for it with ...

GSK has already moved on from its decision to drop a cancer asset on Tuesday by snagging a late-stage liver disease candidate ...

Locally inspired pitas and traditional Israeli street food are being served out of a new stand in downtown Los Angeles ...